Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma
NCT ID: NCT07127614
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
25 participants
OBSERVATIONAL
2025-08-10
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
NCT03837613
Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
NCT03727594
PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
NCT03163797
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
NCT02047201
Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
Patients with biopsy proven oral squamous cell carcinoma with the edition T1or T2 N0 based on TNM staging by American Joint cancer center AJCC 8th edition
MRI
pre-operative MRI scan
Histo-Pathological examination of the resected tumor tissues
histo-pathological examination of the resected tumor tissues with the lymph nodes involved to determine the pathological depth of invasion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
pre-operative MRI scan
Histo-Pathological examination of the resected tumor tissues
histo-pathological examination of the resected tumor tissues with the lymph nodes involved to determine the pathological depth of invasion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The primary tumor has a depth of invasion (DOI) greater than 4 mm
* Clinical N0 status confirmed by reasonable parameters includes computed tomography CT, MRI, -Ultrasonography,( US fine needle aspiration in suspected lymph nodes )
* The primary tumor must be reliably resected to a clear margin without the need for entry of the neck for reconstruction
Exclusion Criteria
* Proven or suspected positive neck node
* Patient with distant metastasis
* Patient with gross injury to the neck that precludes proper surgical dissection.
* Patient with a history of radiotherapy to the neck
* Recurrent cases of OCSCC or recurrent node disease
* Patient with previous neck node biopsy or previous neck dissection
* Patient with a medical condition or performance that interferes with the surgical intervention as judged by the specialist physician
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Islam Mohamed Mohamed Ali
Assistant Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wael A ElMohandes, PhD
Role: STUDY_DIRECTOR
oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University
Ahmed M Alfar, PhD
Role: STUDY_CHAIR
oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University
Mohamed A Mohamed, PhD
Role: STUDY_CHAIR
oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University
Mohamed AW Amin, PhD
Role: STUDY_CHAIR
oral and maxillofacial surgery, Faculty of Dental Medicine, Al-Azhar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AL Sayed Galal Hospital Al-Azhar University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1008/2042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.